2024 forecast: Biden admin efforts show there's no pricing relief on the horizon for pharma
Fierce Pharma
DECEMBER 19, 2023
As the biopharma world readies for the turn of the calendar, the all-too-familiar topic of drug pricing once again presents an industry-wide overhang. drug prices coming out of Washington, the Biden administration is clearly emboldened on the topic. Based on the series of measures centered on U.S.
Let's personalize your content